Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **long non-coding RNA transcript (lncRNA)** is an RNA molecule typically longer than 200 nucleotides that is not translated into protein[1][7][9]. lncRNAs are a diverse group of transcripts transcribed by RNA polymerase II, and include various subtypes such as intergenic, intronic, sense, and antisense lncRNAs[1][4]. They are involved in the regulation of gene expression on multiple levels (epigenetic, transcriptional, post-transcriptional), chromatin organization, maintenance of genomic stability, and in cellular responses to external stimuli[3][4][5][6][8]. Dysregulated lncRNA expression has been implicated in numerous diseases, including cancers, neurodegenerative and cardiovascular disorders, and immune-related conditions[3][4][5]. While individual lncRNAs (e.g., HOTAIR, MALAT1, Xist) can serve as important biomarkers or therapeutic targets, "long non-coding RNA transcript" refers generically to a class of molecules and not to a specific targetable entity[3][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long non-coding RNA transcript (lncRNA).